Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.66 Insider Own3.45% Shs Outstand47.53M Perf Week-8.26%
Market Cap1.17B Forward P/E- EPS next Y-0.58 Insider Trans-0.85% Shs Float46.71M Perf Month-29.13%
Income-30.44M PEG- EPS next Q-0.22 Inst Own97.89% Short Float6.95% Perf Quarter-31.13%
Sales399.25M P/S2.92 EPS this Y-10.37% Inst Trans-1.47% Short Ratio4.80 Perf Half Y-37.85%
Book/sh9.81 P/B2.46 EPS next Y20.94% ROA-5.08% Short Interest3.25M Perf Year-43.06%
Cash/sh2.84 P/C8.49 EPS next 5Y20.00% ROE-6.60% 52W Range25.20 - 59.61 Perf YTD-32.50%
Dividend Est.- P/FCF- EPS past 5Y-1.17% ROI-5.66% 52W High-59.59% Beta1.38
Dividend TTM- Quick Ratio2.66 Sales past 5Y15.61% Gross Margin74.86% 52W Low-4.40% ATR (14)1.36
Dividend Ex-Date- Current Ratio3.57 EPS Y/Y TTM35.40% Oper. Margin-7.95% RSI (14)26.90 Volatility4.35% 4.53%
Employees1200 Debt/Eq0.16 Sales Y/Y TTM20.84% Profit Margin-7.62% Recom1.22 Target Price54.38
Option/ShortYes / Yes LT Debt/Eq0.15 EPS Q/Q-132.16% Payout- Rel Volume0.83 Prev Close25.31
Sales Surprise2.76% EPS Surprise6.58% Sales Q/Q21.03% EarningsMay 01 AMC Avg Volume676.22K Price24.09
SMA20-16.24% SMA50-24.90% SMA200-38.99% Trades Volume561,606 Change-4.82%
Date Action Analyst Rating Change Price Target Change
Oct-23-23Initiated JMP Securities Mkt Outperform $60
Sep-29-23Initiated UBS Buy $56
Aug-05-21Downgrade Oppenheimer Outperform → Perform
Dec-18-20Reiterated Needham Buy $53 → $63
Nov-06-20Reiterated Needham Buy $63 → $53
Apr-07-20Initiated Oppenheimer Outperform $45
Feb-06-20Initiated BTIG Research Buy $42
Jan-24-20Reiterated Needham Buy $39 → $48
Aug-13-19Downgrade Northland Capital Outperform → Market Perform $30
Apr-12-19Initiated JP Morgan Overweight $37
Apr-10-24 08:00AM
Mar-26-24 08:00AM
Mar-22-24 06:40AM
Mar-07-24 09:01AM
Feb-28-24 12:47AM
11:30AM Loading…
Feb-16-24 11:30AM
Feb-15-24 07:00PM
Feb-12-24 09:16AM
Jan-25-24 08:00AM
Jan-08-24 08:00AM
08:00AM Loading…
Jan-04-24 08:00AM
Dec-20-23 08:00AM
Nov-15-23 09:55AM
Nov-14-23 08:00AM
Nov-06-23 12:00PM
Nov-02-23 03:14PM
Nov-01-23 06:22PM
Oct-31-23 08:00AM
Oct-11-23 08:00AM
Sep-29-23 09:40AM
11:45AM Loading…
Sep-11-23 11:45AM
Sep-09-23 07:32PM
Jul-29-23 01:10AM
Jul-27-23 08:50AM
Jul-26-23 07:49AM
Jul-25-23 08:00PM
Jul-21-23 08:00AM
Jul-03-23 08:00AM
May-25-23 04:02AM
May-04-23 06:21AM
May-03-23 10:50AM
May-02-23 05:25PM
Apr-19-23 08:00AM
Apr-17-23 10:42AM
Apr-11-23 08:00AM
Apr-03-23 08:00AM
Apr-01-23 09:41PM
Mar-27-23 08:29AM
Mar-18-23 09:14AM
Feb-25-23 02:14PM
Feb-21-23 05:15PM
Feb-17-23 08:00AM
Jan-31-23 08:00AM
Jan-24-23 08:00AM
Jan-09-23 08:00AM
Dec-31-22 08:07AM
Dec-20-22 08:00AM
Dec-08-22 10:30AM
Dec-04-22 07:20AM
Nov-08-22 08:00AM
Nov-01-22 05:55PM
Oct-26-22 10:01AM
Oct-25-22 10:01AM
Oct-11-22 08:00AM
Oct-09-22 08:53AM
Sep-06-22 08:00AM
Aug-16-22 08:00AM
Aug-02-22 05:15PM
Jul-28-22 09:44AM
Jul-20-22 08:00AM
Jul-12-22 08:00AM
Jul-06-22 07:09PM
Jun-18-22 09:31AM
Jun-07-22 08:00AM
Jun-01-22 01:16PM
May-05-22 12:45PM
May-04-22 03:39PM
May-03-22 05:15PM
May-02-22 08:30AM
Apr-28-22 05:45PM
Apr-12-22 08:00AM
Apr-11-22 08:00AM
Apr-09-22 09:43AM
Feb-23-22 07:23AM
Feb-16-22 10:00AM
Feb-15-22 05:15PM
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Noznesky Justin JChief Mktg & Strategy OfficerApr 01 '24Sale30.391,50045,58572,784Apr 03 08:41 AM
Dahlquist Karl S.Chief Legal OfficerMar 18 '24Sale32.161,88560,62250,954Mar 20 08:41 AM
Noznesky Justin JChief Mktg & Strategy OfficerMar 12 '24Sale36.721,50055,08074,284Mar 14 08:55 AM
Dahlquist Karl S.Chief Legal OfficerMar 05 '24Sale37.368,231307,51052,839Mar 07 07:28 AM
Wirick Angela LChief Financial OfficerMar 01 '24Option Exercise16.955,00084,750139,070Mar 05 04:46 PM
WHITE ROBERT S.DirectorFeb 23 '24Option Exercise15.9610,000159,60088,985Feb 27 09:00 AM
Dahlquist Karl S.Chief Legal OfficerNov 01 '23Sale34.431,24842,96930,789Nov 03 08:40 AM
Dahlquist Karl S.Chief Legal OfficerJul 26 '23Sale57.093,417195,07732,037Jul 28 08:39 AM
Prange KarenDirectorJun 08 '23Sale47.8971334,14616,140Jun 12 08:59 AM
Dahlquist Karl S.Chief Legal OfficerJun 06 '23Sale47.031,42266,87734,897Jun 07 08:43 AM
Yuen MaggieDirectorMay 26 '23Sale47.044,313202,8844,682May 30 04:05 PM
Dahlquist Karl S.Chief Legal OfficerMay 01 '23Sale44.834,417198,01436,319May 03 04:03 PM